What's Happening?
Researchers at the University of Southern California have advanced the understanding of epigenetic clocks by analyzing gene transcription in relation to five popular clock predictors: Hannum, Horvath, PhenoAge, GrimAge, and DunedinPACE. Epigenetic clocks use
DNA methylation markers to estimate biological age and predict age-related diseases. While these clocks have been effective, the underlying mechanisms of how methylation profiles correlate with specific outcomes have been unclear. The USC study, published in npj Aging, investigated the gene expression associated with each clock, revealing that despite distinct gene expression changes, they converge on four fundamental features of aging: metabolic, developmental, immune, and regulatory processes. The study also found a disconnect between affected genes and the CpG sites in each clock, with a large majority of differentially expressed genes not being located near the clock's CpG sites. For instance, the Horvath clock's 353 CpGs were linked to only 49 differentially expressed genes, while DunedinPACE's 173 CpGs were associated with 3,204. The researchers also developed new models called transcriptomic aging gene scores (TAGS), which in some cases predicted outcomes like frailty, disability, and cardiovascular health as strongly or more strongly than DNA methylation scores alone.
Why It's Important?
This research is important because it moves beyond simply predicting biological age to understanding the specific genetic and biological processes involved in epigenetic aging. By linking epigenetic clocks to gene transcription, the study provides a more granular view of how aging manifests at a molecular level. This enhanced interpretability could lead to more precise and clinically useful diagnostic tools. For the U.S. healthcare system, a deeper understanding of these mechanisms could pave the way for targeted interventions to slow or reverse biological aging, potentially reducing the burden of age-related diseases. The development of TAGS, which reflect more immediate processes, could offer a new avenue for assessing current health states and identifying individuals at higher risk for age-related conditions. This could transform preventive medicine and personalized treatment strategies, especially given the growing aging population in the U.S. and the associated healthcare costs.
What's Next?
The researchers anticipate that future advancements in epigenetic clocks will involve integrating multi-omics data, such as metabolomics and proteomics, to increase precision and interpretability. The goal is to move beyond current research tools towards personalized medicine, where these clocks could be used in clinical settings. Em Arpawong, Research Associate Professor of Gerontology at the USC Leonard Davis School of Gerontology, envisions a future where biological age predictions become as standard as pediatric growth charts, allowing clinicians to track an individual's biological aging and intervene with targeted strategies. This would require larger, more robust studies to validate these clocks and ensure their reliability in diverse populations. The development of more interpretable clocks, like PhysAge, which breaks down the overall score into component parts related to specific health markers, is a step towards making these tools more actionable for both patients and healthcare providers.
Beyond the Headlines
The deeper implications of this research extend to the ethical and societal dimensions of aging. As the ability to accurately measure and potentially manipulate biological age improves, questions will arise about access to such technologies and their impact on social equity. The concept of a 'biological age' could influence insurance policies, employment opportunities, and even personal identity. Furthermore, the study highlights the complexity of biological aging, demonstrating that different epigenetic clocks, while all measuring aspects of aging, do so through distinct molecular pathways. This suggests that aging is not a monolithic process but a multifaceted one, requiring a comprehensive approach to intervention. The potential to identify and target specific inflammatory or neurotrophic pathways through epigenetic insights could revolutionize how chronic diseases are managed, shifting the focus from treating symptoms to addressing the root causes of age-related decline.
